Additional file 1: of ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals Chi-Ping Huang Jinbo Chen Chi-Cheng Chen Guodong Liu Yong Zhang Edward Messing Shuyuan Yeh Chawnshang Chang 10.6084/m9.figshare.8318807.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_ASC-J9_increases_the_bladder_cancer_chemotherapy_efficacy_via_altering_the_androgen_receptor_AR_and_NF-_B_survival_signals/8318807 Figure S1. The illustration of xenografts and timeline of treatment regimen with Cisplatin (Cis) and ASC-J9® (ASC). Red arrows = ASC, black arrows = Cis. (PDF 84 kb) 2019-06-24 05:00:00 Bladder cancer Androgen receptor NF-κB ASC-J9® Cisplatin